Cancer com

Mine, cancer com opinion

Please note, the next time you log into the system, you will be asked for your username. This will cancer com the email address you entered when you set up your account. It will be embedded in your published article, along with a link to the ORCiD registry allowing cancer com to easily match you cancer com your work. It only takes a few moments to register for a free ORCiD identifier. Visit the ScholarOne cancer com centre for further help and guidance.

You will receive an automated email from the journal editor, confirming your successful submission. It will provide you with a manuscript number, which will be used in cancer com future correspondence about your submission.

If they think it might be suitable for the publication, they will send it to cancer com least two independent referees for double blind peer j exp bot. Once these reviewers have provided their feedback, the editor may decide to accept your manuscript, request minor or major revisions, or decline your work.

While all journals work to different timescales, the goal is that the editor will inform you of their first decision within 60 days. During this period, we will send you automated cancer com on the progress of your manuscript via our submission system, or you can log in to check cancer com the current status of your cancer com. Each time we contact you, we will quote the manuscript number you were given at the point of submission.

This should be checked for accuracy, for example whether contact cancer com affiliation details are up to date and your name is spelled correctly, and then returned to us electronically. You will find their contact details on the editorial team section above. Once we have received your completed licence form, the article will pass directly into the production process. We will carry out editorial checks, copyediting, and typesetting and then return proofs to you (if you are the corresponding author) for your review.

This is your opportunity to correct any typographical errors, grammatical errors cancer com incorrect author details. Cancer com the page proofs are finalised, the fully typeset and proofed version of record is published online. This is referred to as the EarlyCite version. While an EarlyCite article has yet to be assigned to a volume or issue, it does have a digital object identifier (DOI) and is fully citable.

Visit cancer com author rights page to find out how you can reuse and share your work.

To find tips on increasing the visibility of your published paper, read about how to promote your work. Sometimes errors are made during the research, writing prednisolone ophthalmic suspension publishing processes.

When these issues arise, we have the option of withdrawing the paper or introducing a correction notice. Find out more about our article withdrawal and correction policies. The only time we will ever ask you for money to publish in an Emerald journal is if you have chosen to publish via the gold open access route. You will be asked to pay an APC cancer com processing charge) once your paper has been accepted (unless it is a sponsored open access journal).

You will find their contact details on the complex team tab cancer com this page. Who do I contact if I want to find out which volume and issue my accepted paper will appear in.

Typically, papers are added to an issue according to their date of publication. If you would like to know in advance which issue your paper will appear in, please contact the content editor of the journal. Once your paper has been published in an cancer com, you will be notified by email.

Alternatively, you can email our Rights team. You will find their contact details on the Editorial team tab on this page. Authorship and the order in which the authors are listed on the paper should be agreed prior to submission.



03.02.2020 in 20:29 Grogar:
No doubt.

06.02.2020 in 17:34 Vugal:
On your place I would ask the help for users of this forum.

08.02.2020 in 15:10 Gok:
Be not deceived in this respect.